News

Acadia Realty Trust To Present At Nareit’s REITweek®: 2025 Investor Conference
Acadia Realty Trust (NYSE: AKR) ("Acadia" or the "Company") today announced that it will participate in NAREIT’s REITweek®: 2025 Investor Conference.
Le Lézard3d
Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Acadia Pharmaceuticals Inc. today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 4:00 p.m. Eastern Time.
Medical Marketing & Media4d
The Escalator: Acadia Pharmaceuticals, Indivior, Takeda and more
Australian biotech TekCyte Limited appointed a new co-CEO leadership team consisting of Tony Simula, TekCyte’s founding CEO, as well as Tara James, a commercial strategist and founder of Small and ...
SaltWire4dOpinion
COMMENTARY: Acadia University must be transparent with its community
Acadia has long branded itself as a university that “balances excellence with a strong community spirit.” That promise rings ...
HCA Healthcare (HCA) Gets a Buy from Cantor Fitzgerald
Detailed price information for Hca Holdings Inc (HCA-N) from The Globe and Mail including charting and trades.
Acadia Parish urges hurricane prep and social media updates
Acadia Parish officials are preparing for hurricane season by ensuring effective communication with residents, working with ...
Acadia Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Allyson McMillan-Youngblood as Senior Vice President, Rare Disease Franchise. In this role Allyson will be joining ...